Trial Profile
A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Atorvastatin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs Isavuconazonium (Primary) ; Atorvastatin
- Indications Aspergillosis; Candidiasis; Zygomycosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 13 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 30 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2012 Actual initiation date (Aug 2012) added as reported by ClinicalTrials.gov.